KRT8 and neoplasm: We detected an increased exposure of the TS1 target, K8 in particular in small necrotic areas in tumours after 5 and 3 days of177Lu-DOTA-Tyr3-octreotate treatment in both the NCI-H69 SCLC and midgut GOT1 xenografts.